2006TumoriRequires access

Vitamin E succinate induced apoptosis of MDA-MB-435 human breast cancer cells

Wei Zhang

Open publisher page 1 citations

Abstract

Objective:To investigate the growth inhibition and apoptosis induction effect of vitamin E succinate (VES) on MDA-MB-435 human breast cancer cells and to analyze the changes of Fas expression in this process. Methods:MDA-MB-435 human breast cancer cells were treated with VES at concentrations of 5μg/mL, 10μg/mL, and 20 μg/mL for 12, 24, and 48 h, respectively. The inhibitory effect of VES on cell proliferation was measured with MTT assay. Cell cycle and cell surface Fas expression were analyzed by flow cytometry. Apoptotic index was measured by TUNEL method. Fas protein level was detected by Western blotting assay. Results:VES had significant inhibitory effect on the growth of MDA-MB-435 human breast cancer cells. The inhibitory effect was in a time- and dose-dependent manner. Flow cytometry analysis showed that the apoptotic rate rose from 1.5% to 13.1%,20.2%,and 46.5% after treatment with VES for 48 h at the concentrations of 5μg/mL,10μg/mL,and 20μg/mL,respectively. Both apoptotic index and Fas expression of MDA-MB-435 cells increased after the treatment with VES. Apoptotic index rose from 1.1±0.4 to 10.8±1.0,30.4±2.7,and 51.4±4.7 after VES treatment. Fas protein level increased 1.3, 1.9, and 4.3 folds, respectively. The mean fluorescence intensity of Fas on cell surface rose from 46.2 to 59.66, 84.54, and 103.41. Conclusion:VES had significant growth inhibition and apoptosis induction effect on MDA-MB-435 estrogen receptor-negative breast cancer cells. The mechanism involved up-regulation of Fas on the surface of cancer cells.

About this research paper

What this paper is about

Objective:To investigate the growth inhibition and apoptosis induction effect of vitamin E succinate (VES) on MDA-MB-435 human breast cancer cells and to analyze the changes of Fas expression in this process. Methods:MDA-MB-435 human breast cancer cells were treated with VES at concentrations of 5μg/mL, 10μg/mL, and 20 μg/mL for 12, 24, and 48 h, respectively. The inhibitory effect of VES on cell proliferation was measured with MTT assay. Cell cycle and cell surface Fas expression were analyzed by flow cytometry. Apoptotic index was measured by TUNEL method. Fas protein level was detected by Western blotting assay. Results:VES had significant inhibitory effect on the growth of MDA-MB-435 human breast cancer cells. The inhibitory effect was in a time- and dose-dependent manner. Flow cytometry analysis showed that the apoptotic rate rose from 1.5% to 13.1%,20.2%,and 46.5% after treatment with VES for 48 h at the concentrations of 5μg/mL,10μg/mL,and 20μg/mL,respectively. Both apoptotic index and Fas expression of MDA-MB-435 cells increased after the treatment with VES. Apoptotic index rose from 1.1±0.4 to 10.8±1.0,30.4±2.7,and 51.4±4.7 after VES treatment. Fas protein level increased 1.3, 1.9, and 4.3 folds, respectively. The mean fluorescence intensity of Fas on cell surface rose from 46.2 to 59.66, 84.54, and 103.41. Conclusion:VES had significant growth inhibition and apoptosis induction effect on MDA-MB-435 estrogen receptor-negative breast cancer cells. The mechanism involved up-regulation of Fas on the surface of cancer cells.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the growth inhibition and apoptosis induction effect of vitamin E succinate (VES) on MDA-MB-435 human breast cancer cells and to analyze the changes of Fas expression in this process. Methods:MDA-MB-435 human breast cancer cells were treated with VES at concentrations of 5μg/mL, 10μg/mL, and 20 μg/mL for 12, 24, and 48 h, respectively. The inhibitory effect of VES on cell proliferation was measured with MTT assay. Cell cycle and cell surface Fas expression were analyzed by flow cytometry. Apoptotic index was measured by TUNEL method. Fas protein level was detected by Western blotting assay. Results:VES had significant inhibitory effect on the growth of MDA-MB-435 human breast cancer cells. The inhibitory effect was in a time- and dose-dependent manner. Flow cytometry analysis showed that the apoptotic rate rose from 1.5% to 13.1%,20.2%,and 46.5% after treatment with VES for 48 h at the concentrations of 5μg/mL,10μg/mL,and 20μg/mL,respectively. Both apoptotic index and Fas expression of MDA-MB-435 cells increased after the treatment with VES. Apoptotic index rose from 1.1±0.4 to 10.8±1.0,30.4±2.7,and 51.4±4.7 after VES treatment. Fas protein level increased 1.3, 1.9, and 4.3 folds, respectively. The mean fluorescence intensity of Fas on cell surface rose from 46.2 to 59.66, 84.54, and 103.41. Conclusion:VES had significant growth inhibition and apoptosis induction effect on MDA-MB-435 estrogen receptor-negative breast cancer cells. The mechanism involved up-regulation of Fas on the surface of cancer cells.

Key concepts: Apoptosis, Flow cytometry, TUNEL assay, Fas ligand, MTT assay, Vitamin E, Molecular biology, Cell growth

Related papers

Back to paper searchBrowse research topicsOriginal source
Vitamin E succinate induced apoptosis of MDA-MB-435 human breast cancer cells — Research Paper | ScholarLens